{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T09:22:11Z","timestamp":1774689731290,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR34314\/Med\/29\/1481\/2019"],"award-info":[{"award-number":["BT\/PR34314\/Med\/29\/1481\/2019"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR34314\/Med\/29\/1481\/2019"],"award-info":[{"award-number":["BT\/PR34314\/Med\/29\/1481\/2019"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11033-024-10014-9","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T13:02:52Z","timestamp":1729774972000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prevalence of rifampicin and isoniazid mono-resistance among cases of pulmonary tuberculosis from Western Uttar Pradesh, North India"],"prefix":"10.1007","volume":"51","author":[{"given":"Roopendra","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagdeep Singh","family":"Sohal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay Vir","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devendra Singh","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,24]]},"reference":[{"key":"10014_CR1","unstructured":"World Health Organization (2023) Geneva, Switzerland: WHO; 2023. Global tuberculosis report (Accessed on 18.06.2024)"},{"key":"10014_CR2","unstructured":"Indian TB (2023) report https:\/\/tbcindia.gov.in\/showfile.php?lid=3680 (Accessed on 18.06.2024)"},{"key":"10014_CR3","doi-asserted-by":"publisher","first-page":"e0152933","DOI":"10.1371\/journal.pone.0152933","volume":"11","author":"L Villegas","year":"2016","unstructured":"Villegas L, Otero L, Sterling TR et al (2016) Prevalence, risk factors, and treatment outcomes of isoniazid- and rifampicin- mono-resistant pulmonary tuberculosis in Lima, Peru. PLoS ONE 11:e0152933","journal-title":"PLoS ONE"},{"issue":"12","key":"10014_CR4","doi-asserted-by":"publisher","first-page":"1800392","DOI":"10.2807\/1560-7917.ES.2019.24.12.1800392","volume":"24","author":"B Karo","year":"2019","unstructured":"Karo B, Kohlenberg A, Hollo V et al (2019) Isoniazid (INH) mono-resistance and tuberculosis (TB) treatment success: analysis of European surveillance data, 2002 to 2014. Euro Surveill 24(12):1800392","journal-title":"Euro Surveill"},{"key":"10014_CR5","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1128\/JCM.00718-11","volume":"49","author":"P Ioannidis","year":"2011","unstructured":"Ioannidis P, Papaventsis D, Karabela S et al (2011) Cepheid GeneXpert MTB\/RIF assay for Mycobacterium tuberculosis detection and rifampin resistance identification in patients with substantial clinical indications of tuberculosis and smear-negative microscopy results. J Clin Microbiol 49:3068\u20133070","journal-title":"J Clin Microbiol"},{"issue":"8","key":"10014_CR6","first-page":"767","volume":"62","author":"JQ Farooqi","year":"2012","unstructured":"Farooqi JQ, Khan E, Alam SM et al (2012) Line probe assay for detection of rifampicin and isoniazid resistant tuberculosis in Pakistan. J Pak Med Assoc 62(8):767\u2013772","journal-title":"J Pak Med Assoc"},{"issue":"11","key":"10014_CR7","doi-asserted-by":"publisher","first-page":"e031663","DOI":"10.1136\/bmjopen-2019-031663","volume":"9","author":"NR Mvelase","year":"2019","unstructured":"Mvelase NR, Balakrishna Y, Lutchminarain K et al (2019) Evolving rifampicin and isoniazid mono-resistance in a high multidrug-resistant and extensively drug-resistant tuberculosis region: a retrospective data analysis. BMJ Open 9(11):e031663","journal-title":"BMJ Open"},{"key":"10014_CR8","doi-asserted-by":"crossref","unstructured":"Micheni LN, Kassaza K, Kinyi H et al (2021) Rifampicin and isoniazid drug resistance among patients diagnosed with pulmonary tuberculosis in southwestern Uganda. PLoS ONE 16(10):e0259221","DOI":"10.1371\/journal.pone.0259221"},{"issue":"2","key":"10014_CR9","doi-asserted-by":"publisher","first-page":"ofab018","DOI":"10.1093\/ofid\/ofab018","volume":"8","author":"JH Malenfant","year":"2021","unstructured":"Malenfant JH, Brewer TF (2021) Rifampicin mono-resistant tuberculosis-a review of an uncommon but growing challenge for global tuberculosis control. Open Forum Infect Dis 8(2):ofab018","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"10014_CR10","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1179\/2046905515Y.0000000041","volume":"36","author":"S Prajapati","year":"2016","unstructured":"Prajapati S, Upadhyay K, Mukherjee A et al (2016) High prevalence of primary drug resistance in children with intrathoracic tuberculosis in India. Paediatr Int Child Health 36(3):214\u2013218","journal-title":"Paediatr Int Child Health"},{"issue":"2","key":"10014_CR11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ijtb.2019.04.001","volume":"66","author":"K Garg","year":"2019","unstructured":"Garg K, Saini V, Dhillon R et al (2019) Isoniazid mono-resistant tuberculosis: time to take it seriously. Indian J Tuberc 66(2):247\u2013252","journal-title":"Indian J Tuberc"},{"issue":"1","key":"10014_CR12","doi-asserted-by":"publisher","first-page":"17552","DOI":"10.1038\/s41598-020-74432-y","volume":"10","author":"SS Shivekar","year":"2020","unstructured":"Shivekar SS, Kaliaperumal V, Brammacharry U et al (2020) Prevalence and factors associated with multidrug-resistant tuberculosis in South India. Sci Rep 10(1):17552","journal-title":"Sci Rep"},{"issue":"2","key":"10014_CR13","doi-asserted-by":"publisher","first-page":"116159","DOI":"10.1016\/j.diagmicrobio.2023.116159","volume":"108","author":"P Jain","year":"2024","unstructured":"Jain P, Ratnam R, Sengupta S et al (2024) High frequency of isoniazid and fluroquinolone resistance among patients with rifampicin sensitive tuberculosis. Diagn Microbiol Infect Dis 108(2):116159","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"10014_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4103\/0975-2870.103323","volume":"5","author":"M Sharma","year":"2012","unstructured":"Sharma M, Misra RN, Gandham NR et al (2012) Comparison of modified Petroff\u2032s and N-acetyl-L-cysteine-sodium hydroxide methods for sputum decontamination in tertiary care hospital in India. Med J Dr D Y Patil Uni 5(2):97\u2013100","journal-title":"Med J Dr D Y Patil Uni"},{"issue":"1","key":"10014_CR15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12866-021-02174-6","volume":"21","author":"AV Singh","year":"2021","unstructured":"Singh AV, Singh S, Yadav A et al (2021) Genetic variability in multidrug-resistant Mycobacterium tuberculosis isolates from patients with pulmonary tuberculosis in North India. BMC Microbiol 21(1):123","journal-title":"BMC Microbiol"},{"key":"10014_CR16","unstructured":"Training Manual for Mycobacterium tuberculosis Culture & Drug Susceptibility Testing, National Tuberculosis Elimination Program (NTEP) (2009) https:\/\/tbcindia.gov.in\/WriteReadData\/l892s\/6995271860Training%20manual%20M%20tuberculosis%20C%20DST.pdf"},{"key":"10014_CR17","first-page":"300","volume":"128","author":"A Jain","year":"2008","unstructured":"Jain A, Mondal R, Prasad R et al (2008) Prevalence of multidrug resistant Mycobacterium tuberculosis in Lucknow, Uttar Pradesh. Indian J Med Res 128:300\u2013306","journal-title":"Indian J Med Res"},{"key":"10014_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4103\/jgid.jgid_167_16","volume":"9","author":"P Sinha","year":"2017","unstructured":"Sinha P, Srivastava GN, Gupta A et al (2017) Association of risk factors and drug resistance pattern in tuberculosis patients in North India. J Global Infect Dis 9:139\u2013145","journal-title":"J Global Infect Dis"},{"issue":"7","key":"10014_CR19","first-page":"147","volume":"7","author":"A Tewari","year":"2018","unstructured":"Tewari A, Choudhary AS, Upadhyay AK (2018) Status of tuberculosis in west Uttar Pradesh. Int J Med Res Health Sci 7(7):147\u2013150","journal-title":"Int J Med Res Health Sci"},{"key":"10014_CR20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S0035-9203(99)90135-9","volume":"93","author":"J Perera","year":"1999","unstructured":"Perera J, Arachchi DM (1999) The optimum relative centrifugal force and centrifugation time for improved sensitivity of smear and culture for detection of Mycobacterium tuberculosis from Sputum. Trans R Soc Trop Med Hyg 93:405\u2013409","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10014_CR21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0041-3879(83)90036-3","volume":"64","author":"CN Paramasivan","year":"1983","unstructured":"Paramasivan CN, Narayana AS, Prabhakar R et al (1983) Effect of storage of sputum specimens at room temperature on smear and culture results. Tubercle 64:119\u2013124","journal-title":"Tubercle"},{"key":"10014_CR22","first-page":"466","volume":"13","author":"AL den Hertog","year":"2009","unstructured":"den Hertog AL, Klatser PR, Anthony RM (2009) Buoyant density of Mycobacterium tuberculosis: implications for sputum processing. Int J Tuberc Lung Dis 13:466\u2013471","journal-title":"Int J Tuberc Lung Dis"},{"key":"10014_CR23","unstructured":"Report of the first National anti-tuberculosis drug resistance survey (2014\u20132016) https:\/\/tbcindia.gov.in\/WriteReadData\/l892s\/4187947827National%20Anti-TB%20Drug%20 Resistance%20Survey.pdf (Accessed on 18.06.2024)"},{"issue":"10","key":"10014_CR24","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.4103\/jfmpc.jfmpc_542_19","volume":"8","author":"J Charan","year":"2019","unstructured":"Charan J, Tank N, Reljic T et al (2019) Prevalence of multidrug resistance tuberculosis in adult patients in India: a systematic review and meta-analysis. J Family Med Prim Care 8(10):3191\u20133201","journal-title":"J Family Med Prim Care"},{"issue":"4","key":"10014_CR25","doi-asserted-by":"publisher","first-page":"547","DOI":"10.4103\/0255-0857.167336","volume":"33","author":"C Thakur","year":"2015","unstructured":"Thakur C, Kumar V, Supta AK (2015) Pattern of drug resistant Mycobacterium tuberculosis isolates in Himachal Pradesh using genotype MTBDR assay. Indian J Med Microbiol 33(4):547\u2013553","journal-title":"Indian J Med Microbiol"},{"issue":"4","key":"10014_CR26","doi-asserted-by":"publisher","first-page":"568","DOI":"10.4103\/ijmm.IJMM_17_321","volume":"35","author":"S Ahmed","year":"2017","unstructured":"Ahmed S, Shukla I, Fatima N et al (2017) Evaluation of genotype MTBDplus line probe assay in detection of rifampicin and isoniazid resistance in comparison to solid culture drug susceptibility testing in a tertiary care centre of western U.P. Indian J Med Microbiol 35(4):568\u2013574","journal-title":"Indian J Med Microbiol"},{"issue":"2","key":"10014_CR27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4103\/IJPM.IJPM_53_16","volume":"60","author":"R Tripathi","year":"2017","unstructured":"Tripathi R, Anupurba S (2017) Multi drug resistant tuberculosis detection and characterization of mutation in Mycobacterium tuberculosis by Genotype MTBDR plus. Indian J Pathol Microbiol 60(2):239\u2013242","journal-title":"Indian J Pathol Microbiol"},{"issue":"4","key":"10014_CR28","first-page":"501","volume":"140","author":"R Singhal","year":"2014","unstructured":"Singhal R, Prasad V, Arora J et al (2014) Detection of multi drug resistance and characterization of mutation in Mycobacterium tuberculosis isolates from North Eastern States of India using genotype MTBDR plus assay. Indian J Med Res 140(4):501\u2013506","journal-title":"Indian J Med Res"},{"key":"10014_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijtb.2024.01.009","author":"M Mishra","year":"2024","unstructured":"Mishra M, Pandey A, Chaturvedi P et al (2024) Mutational analysis in drug resistant Mycobacterium tuberculosis in Western Uttar Pradesh. Indian J Tuberc. https:\/\/doi.org\/10.1016\/j.ijtb.2024.01.009","journal-title":"Indian J Tuberc"},{"issue":"2","key":"10014_CR30","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.22207\/JPAM.13.2.46","volume":"13","author":"S Nudrat","year":"2019","unstructured":"Nudrat S, Farooq U, Maqsood M (2019) Importance of detection of isoniazid and rifampicin mono drug resistance and determining rate of MDR-TB in smear positive sputum samples from a tertiary care hospital of west U.P. India. J Pure Appl Microbiol 13(2):1079\u20131085","journal-title":"J Pure Appl Microbiol"},{"issue":"2","key":"10014_CR31","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1086\/595689","volume":"48","author":"A Cattamanchi","year":"2009","unstructured":"Cattamanchi A, Dantes RB, Metcalfe JZ et al (2009) Clinical characteristics and treatment outcomes of isoniazid mono-resistant tuberculosis. Clin Infect Dis 48(2):179\u2013185","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10014_CR32","first-page":"501","volume":"9","author":"PA LoBue","year":"2005","unstructured":"LoBue PA, Moser KS (2005) Isoniazid- and rifampin-resistant tuberculosis in San Diego County, California, United States, 1993\u20132002. Int J Tuberc Lung Dis 9(5):501\u2013506","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"10014_CR33","doi-asserted-by":"publisher","first-page":"196","DOI":"10.5588\/ijtld.11.0116","volume":"16","author":"E Mukinda","year":"2012","unstructured":"Mukinda E, Theron D, Van der Spuy G et al (2012) Rise in rifampicin-mono resistant tuberculosis in Western Cape, South Africa. Int J Tuberc Lung Dis 16(2):196\u2013202","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-10014-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-024-10014-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-10014-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T04:43:04Z","timestamp":1738730584000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-024-10014-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,24]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10014"],"URL":"https:\/\/doi.org\/10.1007\/s11033-024-10014-9","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,24]]},"assertion":[{"value":"20 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Human Ethics Committee of the ICMR-National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Agra, India, gave ethical approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All the patients were informed before participation in the study and have signed a written consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1091"}}